Hunan Fangsheng Pharmaceutical Co., Ltd. Class ASSE: 603998

Announcement on Soliciting Investor Opinions on Matters Related to 2025 Profit Distribution

· Issued by Hunan Fangsheng Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Soliciting Investor Opinions on Matters Related to 2025 Profit Distribution

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment